CD40LG and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, the observed increase in IgM levels in CML-CNP group may be attributed to CML-CNP’s ability to activate B lymphocytes, enhancing the production of primary immunoglobulin (IgM) as part of the humoral immune response (Mohammadi et al., 2022).